Josh Narrow Elevates to Vice President at The Conafay Group, Strengthening Advocacy Expertise

The Conafay Group Announces Josh Narrow as New Vice President

The Conafay Group (TCG), a notable firm in the realm of government relations located in Washington D.C., has announced a significant leadership change with Josh Narrow being elevated to the position of Vice President. This strategic move comes as TCG recognizes Josh's dedicated service and immense contributions over his eight-year tenure with the organization.

Josh Narrow has built a commendable career advising clients in the life sciences and biodefense sectors, assisting them with federal engagement strategies, non-dilutive funding, and advocacy within legislative and regulatory frameworks. His expertise in these areas has positioned him as a valuable resource for both the firm and its clients, particularly in navigating the complexities of healthcare-related policies and funding opportunities.

Before joining The Conafay Group, Narrow brought substantial experience from his previous positions, which included working in a U.S. senator's Washington office alongside senior health staff on the Senate Aging Committee. Additionally, he served as a strategist at a communications firm, where he was instrumental in creating earned media campaigns for various national advocacy organizations. This multifaceted background has enriched his skill set and broadened his understanding of the health policy landscape.

Josh Narrow holds a degree from The Elliott School of International Affairs at The George Washington University, graduating cum laude. His academic background, combined with his professional experiences, makes him particularly suited to lead efforts at TCG as they continue to advocate for impactful health policies.

Jessica Kenyon, the firm's Chief Executive Officer, expressed her confidence in Narrow's capabilities, stating, "Josh's promotion to Vice President reflects both the depth of expertise he has developed over his eight years with the firm and the trust our clients place in his support. We are proud to recognize his contributions and look forward to his continued leadership."

The Conafay Group, established in 2012 by Stephen R. Conafay, has carved a niche as a federal government affairs consulting firm that combines traditional government relations with a strong emphasis on securing non-dilutive funding for health care. TCG represents a varied clientele that includes biopharmaceutical and medical device companies, academic institutions, and research coalitions, all focused on advancing human health.

With a diverse team of over a dozen professionals who bring experience from Capitol Hill, government agencies, and the pharmaceutical sector, The Conafay Group is well-positioned to provide comprehensive services that meet the evolving needs of its clients. For more information on their services and approach, visit conafaygroup.com.

As healthcare policy remains a critical area of focus amid the ongoing advancements in science and technology, Josh Narrow's leadership role will undoubtedly play a vital part in navigating the intersection of these important fields, ensuring that TCG remains a trusted advocate for its clients.